You have 9 free searches left this month | to do more

pralatrexate

Pralatrexate is a drug used to treat Anaplastic Large Cell Lymphoma, Lymphoma, Multiple Myeloma, and other conditions. Pralatrexate is being actively studied in 4 studies and prior, has been studied in 17.

Top SponsorsTop SitesTop Investigators
Spectrum Pharmaceuticals, IncMemorial Sloan-Kettering Cancer CenterEnrica Marchi, MD
University of VirginiaUniversity of VirginiaJennifer Amengual
Jennifer AmengualDana-Farber Cancer InstituteJean Grem, MD
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Recruiting
  • PTCL
  • CTCL
  • Charlottesville, Virginia
    University of Virginia
2022-02-10
Feb 10, 2022
U
Recruiting
  • Lymphoma, T-Cell
  • Charlottesville, Virginia
    University of Virginia
2022-03-16
Mar 16, 2022
S
Completed
  • Lymphoma, B-Cell
  • Pralatrexate
  • +2 more
  • Beverly Hills, California
  • +10 more
2021-10-07
Oct 7, 2021
C
Recruiting
  • Anaplastic Large Cell Lymphoma
  • +19 more
  • Pembrolizumab
  • Pralatrexate
  • Duarte, California
  • +2 more
2021-08-11
Aug 11, 2021
J
Unknown status
  • Lymphoid Malignancies
  • +4 more
  • Boston, Massachusetts
  • +1 more
2020-02-06
Feb 6, 2020
S
Completed
  • Lymphoma
  • pralatrexate
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
2021-08-20
Aug 20, 2021
M
Completed
  • Refractory Peripheral T-Cell Lymphoma
  • Relapsed T-Cell Lymphoma
  • pralatrexate
  • Vitamin B12 and folic acid
  • Beijing, China
    Beijing Cancer Hospital
2019-09-17
Sep 17, 2019
A
Completed
  • Cutaneous T-cell Lymphoma
  • Vitamin B12
  • +2 more
  • Duarte, California
  • +9 more
2020-01-02
Jan 2, 2020
S
Completed
  • Non-small Cell Lung Cancer
  • Pralatrexate
  • +3 more
  • Bakersfield, California
  • +46 more
2021-02-08
Feb 8, 2021
J
Withdrawn
  • Lymphoma, T-Cell, Peripheral
  • (no location specified)
2018-12-17
Dec 17, 2018
U
Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • pralatrexate
  • +9 more
  • Omaha, Nebraska
    UNMC Eppley Cancer Center at the University of Nebraska Medical
2018-07-13
Jul 13, 2018
U
Completed
  • Anaplastic Large Cell Lymphoma
  • +3 more
  • Scottsdale, Arizona
  • +8 more
2018-05-23
May 23, 2018
M
S
Completed
  • Relapsed or Refractory Peripheral T-cell Lymphoma
  • Pralatrexate
  • Seoul, Seoul, Korea, Republic Of, Korea, Republic of
  • +1 more
2017-11-23
Nov 23, 2017
R
Completed
  • Adenocarcinoma of the Gastroesophageal Junction
  • +16 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Buffalo, New York
  • +1 more
2017-11-14
Nov 14, 2017
T
Unknown status
  • Peripheral T Cell Lymphoma
  • Progression, Disease
  • Pralatrexate
  • Taipei, Taiwan
    Ntional Taiwan University Hospital
2017-05-10
May 10, 2017
K
Completed
  • Adult T-cell Leukemia-Lymphoma
  • KW-0761
  • +3 more
  • Los Angeles, California
  • +19 more
2018-08-21
Aug 21, 2018
M
Completed
  • Relapsed Peripheral T-Cell Lymphoma
  • Refractory Peripheral T-Cell Lymphoma
  • Birmingham, Alabama
  • +151 more
2018-07-06
Jul 6, 2018
S
Completed
  • Multiple Myeloma
  • Stanford, California
    Stanford University School of Medicine
2016-07-05
Jul 5, 2016
M
Completed
  • Advanced Cancers
  • Solid Tumors
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2016-07-01
Jul 1, 2016
O
Completed
  • Adenocarcinoma of the Esophagus
  • +4 more
  • pralatrexate
  • +3 more
  • Columbus, Ohio
    Ohio State University
2016-04-25
Apr 25, 2016
M
Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
2013-06-25
Jun 25, 2013
M
Completed
  • Lung Cancer
  • pralatrexate
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
2013-06-18
Jun 18, 2013